On the shortest trading week of the year thus far, the penny stock of Aethlon Medical, Inc. (AEMD) took almost all of the attention the OTC had to offer today, leading all those listed on the exchange in executed trades. Beating out big daddy Fannie Mae (FNMA), up 789% since we began covering it, and StockTips’ eCrypt Technologies, Inc. (ECRY) by more than 6,000 trades, shares of AEMD stock peaked at 0.72 today, up 860% since we began coverage on it, after a day of record breaking volume. With Time Magazine having named the medical device company’s Aethlon Hemopurifier® one of the 25 best inventions of the year, those who went long on our 0.075 call have plenty to give thanks about this week.
Want to crush the Markets and make profits of $624, $2,897, even $40,656?
Click HERE To Make Sure You Get All Of Our Penny Stock Alerts!
AEMD Stock Quote
Ebola has become the new doomsday play for traders and Aethlon Medical has benefited greatly because of it. The Company’s Aethlon Hemopurifier® is a first-in-class bio-filtration device that targets the rapid elimination of viruses and immunosuppressive proteins from the circulatory system of infected individuals which, to date, has been utilized in the treatment of Ebola, HIV and Hepatitis C virus.
Since the middle of September when he keyword, Ebola, began having a major influence on how publicly traded companies’ stocks traded, AEMD has been a huge success for those who got in around the 0.11 level. Back at that time, AEMD shares barely ever broke past the 500,000 level within a session since they were just another OTC listed medical device company back then with limited revenues that was issuing shares to keep their development stage progressing forward.
Since the 10th of October, roughly one year after the Company’s subsidiary, Exosome Sciences, Inc., commenced operations with a focus on advancing exosome-based strategies to diagnose and monitor the progression of cancer, infectious disease and other life-threatening conditions, AEMD stock has been “en fuego.” It wasn’t until November 14 when Time ran their piece “New Ebola Treatment Filters Virus Out of the Blood” that mentioned how Doctor’s experimenting how to remove the Ebola virus from an infected patient, a doctor at that, attached Aethlon Medical’s Hemopurifier to the dialysis machine that was already filtering the patient’s blood which, over a period of 6.5 hours, successfully extracted the virus from the blood that flows through.
Thanks to an Ebola patient with multiple organ failure, AEMD shareholders have become infected with capital gains due to having bought shares of what has become the best penny stock to trade on the OTC. With the likelihood of future press releases to come and possible collaborations with better funded medical companies sure to have already approached the Company, AEMD stock remains a top choice for those heading into what should be an even slower session on Tuesday.
Looking for the Best Penny Stocks to Buy?
Click HERE To Receive FREE Penny Stock Alerts
About AEMD Stock
Aethlon Medical, Inc. and subsidiary is a medical device company focused on creating innovative devices that address unmet medical needs in cancer, infectious disease and other life-threatening conditions.
Issued and Outstanding: 295,160,194
Last 5 Trading Sessions:
We first alerted AEMD stock to readers back in early 2013 when the penny stock was trading at just 0.075. Having burst past the 40,000,000 shares traded level today, more than 12X the average 3 month volume, those not anticipating an attack by short sellers are foolish to think this momentum can continue heading into Black Friday. The peaking of AEMD stock just after 1:30PM today is a clear indication that a return to the 0.70 range is an unlikely possibility and that closing above 0.50 alone would be risky.
(We are 100% Anti-Spam and will never rent or sell your information) Although many of our picks go up 100, 200% even 4,000%, there is always the chance a stock could move lower.
Please read and understand our rules very carefully:
1. Penny Stocks can be very dangerous, unless you understand the risk involved with them do not try to trade them. Many go up fast and can drop just as fast;
2. Do not risk too much in one company. You can lose it all very quickly;
3. Do not “marry” any one stock. Recognize if you are wrong about a stock, cut your losses and move on to the next stock; and
4. Always use sopp loss orders. We recommend that you use “trailing stops” in order to protect your profits.
If you want updates during trading hours, add us to your Skype: AimHighProfits